| ACC | Anterior cingulate cortex |
| AE | Adverse event |
| AI | Artificial intelligence |
| ANCOVA | Analysis of covariance |
| CGI-I | Clinical Global Impression-Improvement |
| CI | Confidence interval |
| CRED-nf | Consensus on the Reporting of Experimental Design neurofeedback |
| DA | Dopamine agonist |
| DSM-5 | Diagnostic and statistical manual for mental disorders |
| EEG | Electroencephalogram |
| EF | Efficacy Analysis |
| FA | Full Analysis |
| fMRI | Functional magnetic resonance imaging |
| GAD-7 | General Anxiety Disorder Scale |
| HDRS-17 | Hamilton Depression Rating Scale |
| LSMean | Least squared mean |
| MDD | Major depressive disorder |
| MINI | Mini-International Neuropsychiatric Interview |
| NF | Neurofeedback |
| PAI | Positive activity intervention |
| PASS | Positive affect stimulation sustainment |
| PAT | Positive affect treatment |
| PHQ-9 | Patient Health Questionnaire |
| PP | Per Protocol |
| QIDS-SR-16 | Quick Inventory Depressive Symptomatology |
| RDoC | Research domain criteria |
| RS-EFP-NF | Reward system electronic fingerprint neurofeedback |
| SE | Standard error |
| SHAPS-C | Snaith–Hamilton Pleasure Scale |
| SNRIs | Serotonin and norepinephrine reuptake inhibitors |
| SSRIs | Selective serotonin reuptake inhibitors |
| STAR*D | Sequenced treatment alternatives to relieve depression |
| TMS | Transcranial magnetic stimulation |
| VS | Ventral striatum |